These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 18770236)

  • 1. Short- and long-term stability studies on four lyophilised and one cell-associated turkey herpesvirus vaccines against Marek's disease of chickens.
    Siegmann O; Kaleta EF; Schindler P
    Avian Pathol; 1980 Jan; 9(1):21-32. PubMed ID: 18770236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial inhibition by turkey herpesvirus of serotype 2 Marek's disease virus plaque formation and in vivo infectivity.
    Witter RL; Bacon LD; Calvert JG
    Avian Dis; 1994; 38(4):800-9. PubMed ID: 7702514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection and synergism by recombinant fowl pox vaccines expressing genes from Marek's disease virus.
    Nazerian K; Witter RL; Lee LF; Yanagida N
    Avian Dis; 1996; 40(2):368-76. PubMed ID: 8790888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of Marek's disease: a review.
    Purchase HG
    Cancer Res; 1976 Feb; 36(2 pt 2):696-700. PubMed ID: 766959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of optimal conditions for thawing and diluting cell-bound CVI 988 Marek's disease vaccine and stability of the diluted vaccine.
    Geerligs HJ; Hoogendam A
    Avian Dis; 2007 Dec; 51(4):969-73. PubMed ID: 18251410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens.
    Geerligs H; Quanz S; Suurland B; Spijkers IE; Rodenberg J; Davelaar FG; Jongsma B; Kumar M
    Vaccine; 2008 Oct; 26(44):5595-600. PubMed ID: 18706949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marek's disease tumors in chickens vaccinated with turkey herpesvirus vaccine.
    Eidson CS
    Dev Biol Stand; 1982; 52():437-46. PubMed ID: 7166202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Potency tests with HVT-, MHV- and JMV vaccines against Marek's disease].
    Landgraf H; Vielitz E
    Avian Pathol; 1978 Apr; 7(2):193-202. PubMed ID: 18770372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of Marek's disease virus (MDV) CVI-988 CEF65 clone C against challenge infection with three very virulent MDV strains.
    de Boer GF; Groenendal JE; Boerrigter HM; Kok GL; Pol JM
    Avian Dis; 1986; 30(2):276-83. PubMed ID: 3015113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of the efficacy against Marek's disease of cell-free and cell-associated turkey herpesvirus vaccine.
    Eidson CS; Villegas P; Page RK; Kleven SH
    Avian Dis; 1975; 19(3):515-24. PubMed ID: 1164319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Field trials to test the efficacy of polyvalent Marek's disease vaccines in broilers.
    Witter RL; Sharma JM; Lee LF; Opitz HM; Henry CW
    Avian Dis; 1984; 28(1):44-60. PubMed ID: 6326743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of chicken interleukin-2 by turkey herpesvirus increases the immune response against Marek's disease virus but fails to increase protection against virulent challenge.
    Tarpey I; Davis PJ; Sondermeijer P; van Geffen C; Verstegen I; Schijns VE; Kolodsick J; Sundick R
    Avian Pathol; 2007 Feb; 36(1):69-74. PubMed ID: 17364512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of maternal immunity against development of Marek's disease and protective ability of vaccine.
    Yoshida I; Yuasa N; Horiuchi T; Tsubahara H
    Natl Inst Anim Health Q (Tokyo); 1975; 15(1):1-7. PubMed ID: 804667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of infectious bursal disease virus on protection against Marek's disease by turkey herpesvirus vaccine.
    Sharma JM
    Avian Dis; 1984; 28(3):629-40. PubMed ID: 6091603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection by attenuated and polyvalent vaccines against highly virulent strains of Marek's disease virus.
    Witter RL
    Avian Pathol; 1982; 11(1):49-62. PubMed ID: 18770172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyvalent Marek's disease vaccines: safety, efficacy and protective synergism in chickens with maternal antibodies.
    Witter RL; Lee LF
    Avian Pathol; 1984 Jan; 13(1):75-92. PubMed ID: 18766823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein.
    Morgan RW; Gelb J; Schreurs CS; Lütticken D; Rosenberger JK; Sondermeijer PJ
    Avian Dis; 1992; 36(4):858-70. PubMed ID: 1485872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lyophilized turkey herpesvirus (HVT): stability of vaccine and minimum protective dose.
    Zanella A; Bettoni V; Mambelli N
    Avian Pathol; 1974 Jan; 3(1):15-24. PubMed ID: 18777253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Embryo vaccination against Marek's disease with serotypes 1, 2 and 3 vaccines administered singly or in combination.
    Sharma JM; Witter RL
    Avian Dis; 1983; 27(2):453-63. PubMed ID: 6307248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.